A recent study explores the use of a platelet membrane-coated resveratrol nanosystem to address mitochondrial dysfunction and endothelial senescence in atherosclerosis. The research highlights the activation of the FOXM1 pathway, providing insights into potential therapeutic strategies for managing atherosclerotic lesions.
mechanistic study of platelet membrane coated resveratrol nanosystem in mitochondrial dysfunction and endothelial senescence during atherosclerotic lesion development via foxm1 activation
Original title: “Mechanistic Study of Platelet Membrane-Coated Resveratrol Nanosystem in Mitochondrial Dysfunction and Endothelial Senescence During Atherosclerotic Lesion Development via FOXM1 Activation.”